Clinical Trial Update: A Randomized, Double Blind, Multi-center, Active Drug Controlled, Phase III Clinical Trial to Compare the Safety and Efficacy of DWP450 Versus Botox® in Treatment of Post Stroke Upper Limb Spasticity [Phase 3]

View source ↗

Summary

A Phase III randomized trial comparing DWP450 to Botox for post-stroke upper limb spasticity has completed, evaluating safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spasticity
• Stroke

Drugs mentioned

• Botox (OnabotulinumtoxinA)
• DWP450

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Spasticity, Stroke | Phase 3 | Status: COMPLETED